Search results
Results From The WOW.Com Content Network
According to the U.S. Food and Drug Administration (FDA), naltrexone/bupropion is contraindicated in patients who have/are: [4] History of seizures; History of an eating disorder such as bulimia nervosa or anorexia nervosa; Taking opioids, or are in opiate withdrawal. Taken monoamine oxidase inhibitors in the last 14 days; Pregnant
Dasotraline (INN; [1] former developmental code name SEP-225,289) is a serotonin-norepinephrine-dopamine reuptake inhibitor (SNDRI) that was under development by Sunovion for the treatment of attention-deficit hyperactivity disorder (ADHD) and binge eating disorder (BED).
Lisdexamfetamine is an FDA-approved appetite suppressant drug that is indicated (i.e., used clinically) for the treatment of binge eating disorder. [19] The antidepressant fluoxetine is a medication that is approved by the Food and Drug Administration for the treatment of an eating disorder, specifically bulimia nervosa.
Fluoxetine, sold under the brand name Prozac, among others, is an antidepressant medication of the selective serotonin reuptake inhibitor (SSRI) class [2] used for the treatment of major depressive disorder, anxiety, obsessive–compulsive disorder (OCD), panic disorder, premenstrual dysphoric disorder, and bulimia nervosa. [2] It is also ...
The U.S. Food and Drug Administration (FDA) has approved the granule formulation of Neurocrine Biosciences' Ingrezza drug to treat movement disorders associated with Huntington's disease (HD), the ...
A common form of CBT that is used to treat eating disorders is called CBT-Enhanced (CBT-E) and was developed by Christopher G. Fairburn throughout the 1970s and 1980s. . Originally intended for bulimia nervosa specifically, it was eventually extended to all eating disorde
The gene therapy will compete with Australia-based CSL Behring’s Hemgenix, a similar treatment that won FDA approval for hemophilia B in 2022. That drug has a similar list price of $3.5 million ...
REMS, write Singer and Bloom, "has been largely responsible for the underprescription and underuse of clozapine, the only FDA-approved drug for treatment-resistant schizophrenia, the most severe ...